Related references
Note: Only part of the references are listed.CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Characterisation of heterozygous PMS2 variants in French patients with Lynch syndrome
Qing Wang et al.
JOURNAL OF MEDICAL GENETICS (2020)
Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome
Shahid Mahmood Baig et al.
FAMILIAL CANCER (2019)
Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2
Sigurdis Haraldsdottir et al.
NATURE COMMUNICATIONS (2017)
Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD)
N. C. Ramchander et al.
BMC MEDICAL GENETICS (2017)
PMS2 monoallelic mutation carriers: the known unknown
McKinsey L. Goodenberger et al.
GENETICS IN MEDICINE (2016)
Improving performance of multigene panels for genomic analysis of cancer predisposition
Brian H. Shirts et al.
GENETICS IN MEDICINE (2016)
Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome
C. Therkildsen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome
Matthew B. Yurgelun et al.
GASTROENTEROLOGY (2015)
Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk
Sanne W. ten Broeke et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'Care for CMMRD' (C4CMMRD)
Katharina Wimmer et al.
JOURNAL OF MEDICAL GENETICS (2014)
MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer
Bente A. Talseth-Palmer et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2010)
Management of extracolonic tumours in patients with Lynch syndrome
Jan J. Koornstra et al.
LANCET ONCOLOGY (2009)
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
Leigha Senter et al.
GASTROENTEROLOGY (2008)
Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1
Stefan Krueger et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2008)
PMS2 mutations in childhood cancer
M De Vos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Decrease in mortality in Lynch syndrome families because of surveillance
AE De Jong et al.
GASTROENTEROLOGY (2006)
Two PMS2 mutations in a Turcot syndrome family with small bowel cancers
M Agostini et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene
M De Rosa et al.
ONCOGENE (2000)
Share Paper
